MACK
Merrimack Pharmaceuticals Inc

7,933
Loading...
Loading...
News
all
press releases
Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (Merrimack or the Company) announced that the stockholders at a Special Meeting held today overwhelmingly approved adopting a Plan of Dissolution...
Business Wire·1y ago
News Placeholder
More News
News Placeholder
Merrimack Pharmaceuticals, Inc. Announces Anticipated Final Cash Dividend Amount of Initial Liquidating Distribution, Subject to Receipt of Stockholder Approval of Plan of Dissolution
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (Merrimack or the Company) today announced that the Board of Directors intends to declare a liquidating cash dividend in the amount of $15.10 per share...
Business Wire·1y ago
News Placeholder
Merrimack Pharmaceuticals Announces Notification of Plan to Voluntary Delist Common Stock on NASDAQ Subject to Receipt of Stockholder Approval of Plan of Dissolution
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (Merrimack or the Company) today announced that it has filed notice with NASDAQ of the Companys intent to delist its securities from NASDAQ, subject to...
Business Wire·1y ago
News Placeholder
Merrimack Receives $225 Million Milestone Payment from Ipsen
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (Merrimack or the Company) today announced that it has received a $225 million payment which was due from Ipsen, S.A. as a result of its receipt of...
Business Wire·1y ago
News Placeholder
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Sees Large Drop in Short Interest
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK Get Free Report) was the target of a significant decline in short interest in the month of February. As of February 29th, there was short interest...
Zolmax·1y ago
News Placeholder
Merrimack Pharmaceuticals (MACK, $14.72) RSI Indicator left the overbought zone on March 08, 2024
This is a signal that MACK's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Tickeron - Stocks·2y ago
News Placeholder
Merrimack Pharmaceuticals (MACK, $14.77) RSI Indicator left the overbought zone on March 07, 2024
This is a signal that MACK's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Tickeron - Technical Analysis·2y ago
News Placeholder
Merrimack Pharmaceuticals (MACK, $14.77) price may drop as it broke higher Bollinger Band on Mar 07, 2024
This price move could be a signal that MACK may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...
Tickeron - Technical Analysis·2y ago
News Placeholder
Merrimack Reports Full Year 2023 Financial Results
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (Merrimack or the Company) today announced its full year 2023 financial results for the period ended December 31, 2023. As Ipsen reported in February...
Business Wire·2y ago
News Placeholder
Merrimack Pharmaceuticals (MACK, $14.7) RSI Indicator left the overbought zone on March 04, 2024
This is a signal that MACK's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Tickeron - Stocks·2y ago

Latest MACK News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.